Dow helps customers avoid excessive REACH compliance costs

Published: 5-Dec-2008
Media

The Dow Chemical Company has appointed a Dow Only Representative Trustee (ORT) to leverage REACH registrations and reduce costs along its supply chains.


The Dow Chemical Company has appointed a Dow Only Representative Trustee (ORT) to leverage REACH registrations and reduce costs along its supply chains.

Under some specific conditions, the Dow ORT can offer to use the Dow registrations to cover under REACH the so-called "indirect imports" of Dow substances by European Union (EU) importers.

To ensure confidentiality of customers" business information, Dow has selected PricewaterhouseCoopers Advisory in the Netherlands to operate as the trustee.

Dow says the ORT solution will enable its selected direct non-EU customers and importers to avoid excessive REACH compliance costs.

  • Companies:
  • Dow Chemical Company
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Media

Good growth for ingredients, but costs could rise

Read more
In the fast growing API and excipient markets, solubility, taste-masking and functionality are the focus. Susan Birks looks at current trends and issues on the horizon

Trending Articles

  1. CHEMUK EXPO CHEMUK 2025 will return on 21st & 22nd May at the NEC in Birmingham.
  2. Hospira acquires worldwide rights to biogeneric filgrastim and manufacturing facility in Croatia <p>Hospira acquires worldwide rights to a biogeneric version of filgrastim.</p>
  3. Optimising excipients to improve bioavailability Guy Tiene, Director of Strategic Content, That's Nice LLC/Nice Insight, discusses excipient market trends, the use of excipients to improve the poor aqueous solubility of increasingly complex drug candidates and how drug developers choose excipient suppliers
  4. Orion enters supply agreement with Peptonic Medical The contract manufacturing organisation has made a commercial supply agreement for the manufacture and packaging of VagiVital
  5. DOW increases global capacity for solid pharma grade PEGs <p>In response to growing global demand for its products, Dow Chemical Co plans a 30% increase in production capacity for its solid grade Carbowax Sentry polyethylene glycols (PEG).</p>

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Media

Good growth for ingredients, but costs could rise

In the fast growing API and excipient markets, solubility, taste-masking and functionality are the focus. Susan Birks looks at current trends and issues on the horizon
Media

DOW increases global capacity for solid pharma grade PEGs

<p>In response to growing global demand for its products, Dow Chemical Co plans a 30% increase in production capacity for its solid grade Carbowax Sentry polyethylene glycols (PEG).</p>
Media

Dr Reddy's to acquire part Dowpharma's small molecules business

<p>Dr Reddy's Laboratories, of India, has entered into a definitive agreement with The Dow Chemical Company to acquire a portion of Dowpharma Small Molecules business associated with its UK sites in Mirfield and Cambridge. </p>
Media

BioPharma Dynamics proudly sponsor GMCC Excellence Awards

BioPharma Dynamics is proud to continue their headline sponsorship of Greater Manchester Chamber of Commerce Excellence Awards, championing success and achievements of businesses within the Greater Manchester region
Media

Chemspec Europe 2024 conference programme unveiled

A detailed look at key speakers, sessions, and networking opportunities at the international exhibition
Media

Curia receives 2024 CDMO leadership award

Curia recognised for its service in the CDMO industry
Media

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN

Biovian and 3P Biopharmaceuticals, two leading biologics CDMOs, announce their combination to establish a new pan-European leader in their field
Subscribe now